The METTL3/YTHDF2 axis can lead to cisplatin resistance of ovarian cancer by regulating the mRNA stability of IFFO1 in an m6A-dependent manner and inhibiting IFFO1 expression [28]. Here, METTL3 is linked to ovarian cancer.